Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis-Reference-Cited by-同舟云学术

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis

Published:2014-03-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kew Kayleigh M¹,Dias Sofia²,Cates Christopher J¹

Affiliation:

1. St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE

2. University of Bristol; School of Social and Community Medicine; Canynge Hall 39 Whatley Road Bristol UK BS8 2PS

Publisher

Wiley

Subject

Pharmacology (medical)

Reference707 articles.

1. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD;Abrahams;Respiratory Medicine,2013

2. Comparison of BEA2180 to tiotropium and placebo via respimat in patients with chronic obstructive pulmonary disease (COPD) [Abstract];Abrahams;Respirology,2012

3. Jones P Agusti A Chanez P Magnussen H Fabbri L Maroni J Efficacy and safety of aclidinium bromide, a novel long-acting muscarinic antagonist, in patients with moderate to severe COPD [Abstract] European Respiratory Society Annual Congress; Sep 12-16; Vienna 2009 [P2022]

4. A phase III study evaluating aclidinium bromide, a novel long-acting antimuscarinic, in patients with COPD: ACCLAIM/COPD I [Abstract];Jones;Thorax,2009

5. Jones PW Agusti A Chanez P Magnussen H Fabbri L Maroni J A phase III study evaluating aclidinium bromide, a novel long-acting antimuscarinic, in patients with COPD: ACCLAIM/COPD 1 [Abstract] American Thoracic Society International Conference; May 15-20; San Diego 2009 A6180 [Poster #207]

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between Cognitive, Affective, and Respiratory Profiles in Chronic Respiratory Disorders: A Cluster Analysis Approach;Diagnostics;2024-05-30

2. Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial;The Lancet Respiratory Medicine;2024-01

3. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-12-06

4. Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx;BMJ Open Respiratory Research;2023-12

5. The dual-targeting mechanism of an anti-inflammatory diarylheptanoid from Curcuma zedoaria (Christm.) Roscoe with the capacity for β2-adrenoreceptor agonism and NLRP3 inhibition;Chemico-Biological Interactions;2023-12